Metabolically healthy obesity--does it exist? (Q38237010)

31 August 2017

Metabolically healthy obesity--does it exist? (English)

1 reference

31 August 2017

0 references

Patchaya Boonchaya-anant

series ordinal

1

1 reference

PubMed ID

25092577

31 August 2017

Caroline M Apovian

series ordinal

2

1 reference

31 August 2017

1 October 2014

1 reference

Current Atherosclerosis Reports

31 August 2017

1 reference

31 August 2017

16

1 reference

31 August 2017

441

1 reference

31 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-014-0441-1

31 August 2017

0 references

cites work

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Medical Consequences of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Annual medical spending attributable to obesity: payer-and service-specific estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Clinical relevance of adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adiponectin: mechanistic insights and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Mechanisms of inflammatory responses in obese adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The endocrine profile of subcutaneous and visceral adipose tissue of obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The metabolically healthy but obese phenotype in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Dysmetabolic Signals in "Metabolically Healthy" Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Incident cardiovascular disease events in metabolically benign obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

All-cause mortality risk of metabolically healthy obese individuals in NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The metabolically healthy but obese individual presents a favorable inflammation profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Does inflammation determine metabolic health status in obese and nonobese adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Insulin-sensitive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Preadipocyte factor-1 is associated with metabolic profile in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Characterising metabolically healthy obesity in weight-discordant monozygotic twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Defining metabolically healthy obesity: role of dietary and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-014-0441-1

The role of chronic inflammation in obesity-associated cancers

21 January 2018

1 reference

12 December 2020

Adipocyte death, adipose tissue remodeling, and obesity complications

1 reference

12 December 2020

Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis

1 reference

12 December 2020

T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance

1 reference

12 December 2020

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

1 reference

12 December 2020

Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population.

1 reference

12 December 2020

Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus

1 reference

12 December 2020

Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals

1 reference

12 December 2020

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

1 reference

12 December 2020

Effects of a lifestyle intervention in metabolically benign and malign obesity

1 reference

12 December 2020

The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life

1 reference

12 December 2020

Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects

1 reference

12 December 2020

Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies

1 reference

12 December 2020

Infant growth and later body composition: evidence from the 4-component model

1 reference

12 December 2020

10.1007/S11883-014-0441-1

Identifiers

DOI

1 reference

PubMed ID

25092577

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

25092577